HCPLive

Atrial Fibrillation

Latest Headlines

Triple Therapy Risks and Rewards
In this segment of the Peer Exchange, the panelists discuss patients’ misconceptions of the risks associated with use of anticoagulants, and the risks and benefits of using triple therapy with antiplatelets, antithrombotics, and the newer drugs.
How Do Newer Anticoagulants Compare with Warfarin?
In this segment of the Peer Exchange, the panelists discuss the clinical evidence comparing the newer oral anticoagulants to warfarin in terms of reducing stroke and systemic embolism.
Promising Study Results for Ablation Alternatives for Patients with Atrial Fibrillation
Results from 2 trials presented at the recent Heart Rhythm Society meeting suggest that 2 alternative ablation technologies work about as well as those that are commonly used on patients with atrial fibrillation.
COPD Independently Increases Cardiovascular-Related Mortality, Not Stroke
Researchers at ATS 2015 reported chronic obstructive pulmonary disease was a risk factor for cardiovascular disease, but was not independently linked to risk of stroke or systemic embolism.
Opioid Users at Greater Risk for Atrial Fibrillation
Analysis of data from a previous study indicates that opioid use may increase the risk of heart attack by triggering atrial fibrillation.
Wide Variability in Medication Adherence among Patients with Atrial Fibrillation
Research indicates that, despite the relative simplicity of dabigatran regimens, physicians and pharmacists must follow up with patients repeatedly to maximize the chances they’ll adhere to prescriptions.

Most Popular

$vacMongoViewPlus$ $vAR$